427 related articles for article (PubMed ID: 27670139)
1. Cell cycle checkpoint in cancer: a therapeutically targetable double-edged sword.
Visconti R; Della Monica R; Grieco D
J Exp Clin Cancer Res; 2016 Sep; 35(1):153. PubMed ID: 27670139
[TBL] [Abstract][Full Text] [Related]
2. The Fcp1-Wee1-Cdk1 axis affects spindle assembly checkpoint robustness and sensitivity to antimicrotubule cancer drugs.
Visconti R; Della Monica R; Palazzo L; D'Alessio F; Raia M; Improta S; Villa MR; Del Vecchio L; Grieco D
Cell Death Differ; 2015 Sep; 22(9):1551-60. PubMed ID: 25744022
[TBL] [Abstract][Full Text] [Related]
3. Sustaining the spindle assembly checkpoint to improve cancer therapy.
Visconti R; Della Monica R; Grieco D
Mol Cell Oncol; 2016 Jan; 3(1):e1046583. PubMed ID: 27308561
[TBL] [Abstract][Full Text] [Related]
4. The synthetic lethality of targeting cell cycle checkpoints and PARPs in cancer treatment.
Li S; Wang L; Wang Y; Zhang C; Hong Z; Han Z
J Hematol Oncol; 2022 Oct; 15(1):147. PubMed ID: 36253861
[TBL] [Abstract][Full Text] [Related]
5. Differential properties of mitosis-associated events following CHK1 and WEE1 inhibitor treatments in human tongue carcinoma cells.
Nojima H; Homma H; Onozato Y; Kaida A; Harada H; Miura M
Exp Cell Res; 2020 Jan; 386(2):111720. PubMed ID: 31738907
[TBL] [Abstract][Full Text] [Related]
6. Molecular anatomy of the DNA damage and replication checkpoints.
Qin J; Li L
Radiat Res; 2003 Feb; 159(2):139-48. PubMed ID: 12537518
[TBL] [Abstract][Full Text] [Related]
7. G2 checkpoint abrogation and checkpoint kinase-1 targeting in the treatment of cancer.
Bucher N; Britten CD
Br J Cancer; 2008 Feb; 98(3):523-8. PubMed ID: 18231106
[TBL] [Abstract][Full Text] [Related]
8. The DNA-damage effector checkpoint kinase 1 is essential for chromosome segregation and cytokinesis.
Peddibhotla S; Lam MH; Gonzalez-Rimbau M; Rosen JM
Proc Natl Acad Sci U S A; 2009 Mar; 106(13):5159-64. PubMed ID: 19289837
[TBL] [Abstract][Full Text] [Related]
9. Cell cycle involvement in cancer therapy; WEE1 kinase, a potential target as therapeutic strategy.
Vakili-Samiani S; Khanghah OJ; Gholipour E; Najafi F; Zeinalzadeh E; Samadi P; Sarvarian P; Pourvahdani S; Kelaye SK; Hamblin MR; Feizi AAH
Mutat Res; 2022; 824():111776. PubMed ID: 35247630
[TBL] [Abstract][Full Text] [Related]
10. Cell cycle checkpoints and beyond: Exploiting the ATR/CHK1/WEE1 pathway for the treatment of PARP inhibitor-resistant cancer.
Gupta N; Huang TT; Horibata S; Lee JM
Pharmacol Res; 2022 Apr; 178():106162. PubMed ID: 35259479
[TBL] [Abstract][Full Text] [Related]
11. Expanding roles of cell cycle checkpoint inhibitors in radiation oncology.
Hauge S; Eek Mariampillai A; Rødland GE; Bay LTE; Landsverk HB; Syljuåsen RG
Int J Radiat Biol; 2023; 99(6):941-950. PubMed ID: 33877959
[TBL] [Abstract][Full Text] [Related]
12. A subset of cancer cell lines is acutely sensitive to the Chk1 inhibitor MK-8776 as monotherapy due to CDK2 activation in S phase.
Sakurikar N; Thompson R; Montano R; Eastman A
Oncotarget; 2016 Jan; 7(2):1380-94. PubMed ID: 26595527
[TBL] [Abstract][Full Text] [Related]
13. A role for the spindle assembly checkpoint in the DNA damage response.
Palou R; Palou G; Quintana DG
Curr Genet; 2017 May; 63(2):275-280. PubMed ID: 27488803
[TBL] [Abstract][Full Text] [Related]
14. Meiotic Cells Escape Prolonged Spindle Checkpoint Activity Through Premature Silencing and Slippage.
MacKenzie A; Vicory V; Lacefield S
bioRxiv; 2023 Jan; ():. PubMed ID: 36711621
[TBL] [Abstract][Full Text] [Related]
15. An indolocarbazole inhibitor of human checkpoint kinase (Chk1) abrogates cell cycle arrest caused by DNA damage.
Jackson JR; Gilmartin A; Imburgia C; Winkler JD; Marshall LA; Roshak A
Cancer Res; 2000 Feb; 60(3):566-72. PubMed ID: 10676638
[TBL] [Abstract][Full Text] [Related]
16. The multiple checkpoint functions of CHK1 and CHK2 in maintenance of genome stability.
Chen Y; Poon RY
Front Biosci; 2008 May; 13():5016-29. PubMed ID: 18508566
[TBL] [Abstract][Full Text] [Related]
17. Targeting the Checkpoint to Kill Cancer Cells.
Benada J; Macurek L
Biomolecules; 2015 Aug; 5(3):1912-37. PubMed ID: 26295265
[TBL] [Abstract][Full Text] [Related]
18. Working on Genomic Stability: From the S-Phase to Mitosis.
Ovejero S; Bueno A; Sacristán MP
Genes (Basel); 2020 Feb; 11(2):. PubMed ID: 32093406
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Chk1-dependent G2 DNA damage checkpoint radiosensitizes p53 mutant human cells.
Koniaras K; Cuddihy AR; Christopoulos H; Hogg A; O'Connell MJ
Oncogene; 2001 Nov; 20(51):7453-63. PubMed ID: 11709716
[TBL] [Abstract][Full Text] [Related]
20. WEE1 kinase limits CDK activities to safeguard DNA replication and mitotic entry.
Elbæk CR; Petrosius V; Sørensen CS
Mutat Res; 2020; 819-820():111694. PubMed ID: 32120135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
